Genetic analysis reveals functions of atypical polyubiquitin chains

  1. Fernando Meza Gutierrez
  2. Deniz Simsek
  3. Arda Mizrak
  4. Adam Deutschbauer
  5. Hannes Braberg
  6. Jeffrey Johnson
  7. Jiewei Xu
  8. Michael Shales
  9. Michelle Nguyen
  10. Raquel Tamse-Kuehn
  11. Curt Palm
  12. Lars M Steinmetz
  13. Nevan J Krogan
  14. David P Toczyski  Is a corresponding author
  1. University of California, San Francisco, United States
  2. Amgen Research, United States
  3. Lawrence Berkeley National Laboratory, United States
  4. Stanford University, United States
  5. University of California San Francisco, United States

Abstract

Although polyubiquitin chains linked through all lysines of ubiquitin exist, specific functions are well-established only for lysine-48 and lysine-63 linkages in Saccharomyces cerevisiae. To uncover pathways regulated by distinct linkages, genetic interactions between a gene deletion library and a panel of lysine-to-arginine ubiquitin mutants were systematically identified. The K11R mutant had strong genetic interactions with threonine biosynthetic genes. Consistently, we found that K11R mutants import threonine poorly. The K11R mutant also exhibited a strong genetic interaction with a subunit of the anaphase-promoting complex (APC), suggesting a role in cell cycle regulation. K11-linkages are important for vertebrate APC function, but this was not previously described in yeast. We show that the yeast APC also modifies substrates with K11-linkages in vitro, and that those chains contribute to normal APC-substrate turnover in vivo. This study reveals comprehensive genetic interactomes of polyubiquitin chains and characterizes the role of K11-chains in two biological pathways.

Data availability

All datasets generated are included as Supplementary Files 4 (SGA dataset) and 5 (quantitative proteomics).

Article and author information

Author details

  1. Fernando Meza Gutierrez

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5601-7202
  2. Deniz Simsek

    Amgen Research, South San Francisco, United States
    Competing interests
    Deniz Simsek, is affiliated with Amgen Research. The author has no other competing interests to declare..
  3. Arda Mizrak

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  4. Adam Deutschbauer

    Lawrence Berkeley National Laboratory, Berkeley, United States
    Competing interests
    No competing interests declared.
  5. Hannes Braberg

    Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  6. Jeffrey Johnson

    Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  7. Jiewei Xu

    Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  8. Michael Shales

    Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  9. Michelle Nguyen

    Stanford Genome Technology Center, Stanford University, Stanford, United States
    Competing interests
    No competing interests declared.
  10. Raquel Tamse-Kuehn

    Stanford Genome Technology Center, Stanford University, Stanford, United States
    Competing interests
    No competing interests declared.
  11. Curt Palm

    Stanford Genome Technology Center, Stanford University, Stanford, United States
    Competing interests
    No competing interests declared.
  12. Lars M Steinmetz

    Genetics, Stanford University, Stanford, United States
    Competing interests
    No competing interests declared.
  13. Nevan J Krogan

    Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  14. David P Toczyski

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    For correspondence
    dpt4darwin@gmail.com
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5924-0365

Funding

National Institutes of Health (R35 GM118104)

  • David P Toczyski

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2018, Meza Gutierrez et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,064
    views
  • 275
    downloads
  • 12
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Fernando Meza Gutierrez
  2. Deniz Simsek
  3. Arda Mizrak
  4. Adam Deutschbauer
  5. Hannes Braberg
  6. Jeffrey Johnson
  7. Jiewei Xu
  8. Michael Shales
  9. Michelle Nguyen
  10. Raquel Tamse-Kuehn
  11. Curt Palm
  12. Lars M Steinmetz
  13. Nevan J Krogan
  14. David P Toczyski
(2018)
Genetic analysis reveals functions of atypical polyubiquitin chains
eLife 7:e42955.
https://doi.org/10.7554/eLife.42955

Share this article

https://doi.org/10.7554/eLife.42955

Further reading

    1. Biochemistry and Chemical Biology
    2. Genetics and Genomics
    Conor J Howard, Nathan S Abell ... Nathan B Lubock
    Research Article

    Deep Mutational Scanning (DMS) is an emerging method to systematically test the functional consequences of thousands of sequence changes to a protein target in a single experiment. Because of its utility in interpreting both human variant effects and protein structure-function relationships, it holds substantial promise to improve drug discovery and clinical development. However, applications in this domain require improved experimental and analytical methods. To address this need, we report novel DMS methods to precisely and quantitatively interrogate disease-relevant mechanisms, protein-ligand interactions, and assess predicted response to drug treatment. Using these methods, we performed a DMS of the melanocortin-4 receptor (MC4R), a G-protein-coupled receptor (GPCR) implicated in obesity and an active target of drug development efforts. We assessed the effects of >6600 single amino acid substitutions on MC4R’s function across 18 distinct experimental conditions, resulting in >20 million unique measurements. From this, we identified variants that have unique effects on MC4R-mediated Gαs- and Gαq-signaling pathways, which could be used to design drugs that selectively bias MC4R’s activity. We also identified pathogenic variants that are likely amenable to a corrector therapy. Finally, we functionally characterized structural relationships that distinguish the binding of peptide versus small molecule ligands, which could guide compound optimization. Collectively, these results demonstrate that DMS is a powerful method to empower drug discovery and development.

    1. Biochemistry and Chemical Biology
    2. Genetics and Genomics
    Jiale Zhou, Ding Zhao ... Zhanjun Li
    Research Article

    5-Methylcytosine (m5C) is one of the posttranscriptional modifications in mRNA and is involved in the pathogenesis of various diseases. However, the capacity of existing assays for accurately and comprehensively transcriptome-wide m5C mapping still needs improvement. Here, we develop a detection method named DRAM (deaminase and reader protein assisted RNA methylation analysis), in which deaminases (APOBEC1 and TadA-8e) are fused with m5C reader proteins (ALYREF and YBX1) to identify the m5C sites through deamination events neighboring the methylation sites. This antibody-free and bisulfite-free approach provides transcriptome-wide editing regions which are highly overlapped with the publicly available bisulfite-sequencing (BS-seq) datasets and allows for a more stable and comprehensive identification of the m5C loci. In addition, DRAM system even supports ultralow input RNA (10 ng). We anticipate that the DRAM system could pave the way for uncovering further biological functions of m5C modifications.